?Community Outreach and Engagement The SJCCC is committed to the community we serve and addressing its clinical and research needs through education, thoughtful scientific research, community engagement and advocacy, and facilitation of access to care. Our efforts in the community are led by Dr. Carlos Rodriguez-Galindo, the SJCCC Associate Director for Outreach. The SJCCC catchment area is defined as the geographic area around Memphis and each of our 8 affiliate sites in census-tract radii. Based on the 2010 United States census data, this area represents 6,633,683 persons aged 0?19 years, with an ethnic and racial distribution of 69% White, 21% Non-Hispanic Black/African American, and 8% Hispanic. The diverse population in our catchment area includes a large proportion of low- income groups with limited resources who are medically underserved. St. Jude's 56-year-old founding policy, to which we continue to rigorously adhere, is that no patient be denied treatment based on race, ethnicity, religion, or a family's inability to pay. The SJCCC is committed to addressing treatment disparities by making resources readily available to offset not only the cost of treatment but also that of transportation and housing during clinic visits and treatment. As the only NCI-designated Cancer Center focused exclusively on children, our outreach area is further expanded beyond our local community; we also serve as a national and international referral center for pediatric cancer. There is no known variation in childhood cancer incidence and outcomes by geographic region in the United States, and relatively few discrepancies have been identified that disproportionately affect racial and ethnic minorities. Thus, our SJCCC outreach efforts continue to investigate disparities, provide cancer education for children and their parents, advocate at the state and federal level, promote the implementation of health polices relevant to our population (e.g., HPV vaccination), address the needs of an ever-growing population of childhood cancer survivors, and conduct innovative research in these areas. We will also enhance provision of implementation tools locally through our Affiliates, nationally through St. Jude?led collaborative multisite studies, and globally through capacity building and advancement of knowledge to improve the level and quality of pediatric oncology care around the world.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
St. Jude Children's Research Hospital
United States
Zip Code
Sadighi, Zsila S; Curtis, Elizabeth; Zabrowksi, Jennifer et al. (2018) Neurologic impairments from pediatric low-grade glioma by tumor location and timing of diagnosis. Pediatr Blood Cancer 65:e27063
Wierdl, Monika; Tsurkan, Lyudmila; Chi, Liying et al. (2018) Targeting ALK in pediatric RMS does not induce antitumor activity in vivo. Cancer Chemother Pharmacol 82:251-263
Penkert, Rhiannon R; Hurwitz, Julia L; Thomas, Paul et al. (2018) Inflammatory molecule reduction with hydroxyurea therapy in children with sickle cell anemia. Haematologica 103:e50-e54
Turner, Benjamin L; Brenes-Arguedas, Tania; Condit, Richard (2018) Pervasive phosphorus limitation of tree species but not communities in tropical forests. Nature 555:367-370
Gibbs, E B; Kriwacki, R W (2018) Direct detection of carbon and nitrogen nuclei for high-resolution analysis of intrinsically disordered proteins using NMR spectroscopy. Methods 138-139:39-46
Pui, Ching-Hon; Liu, Yiwei; Relling, Mary V (2018) How to solve the problem of hypersensitivity to asparaginase? Pediatr Blood Cancer 65:
Mukkada, Sheena; Smith, Cristel Kate; Aguilar, Delta et al. (2018) Evaluation of a fever-management algorithm in a pediatric cancer center in a low-resource setting. Pediatr Blood Cancer 65:
Buchman, Cameron D; Chai, Sergio C; Chen, Taosheng (2018) A current structural perspective on PXR and CAR in drug metabolism. Expert Opin Drug Metab Toxicol 14:635-647
van Oosterwijk, Jolieke G; Buelow, Daelynn R; Drenberg, Christina D et al. (2018) Hypoxia-induced upregulation of BMX kinase mediates therapeutic resistance in acute myeloid leukemia. J Clin Invest 128:369-380
Howell, Carrie R; Wilson, Carmen L; Ehrhardt, Matthew J et al. (2018) Clinical impact of sedentary behaviors in adult survivors of acute lymphoblastic leukemia: A report from the St. Jude Lifetime Cohort study. Cancer 124:1036-1043

Showing the most recent 10 out of 6764 publications